The Guangxi epidemic prevention drug precision delivery platform will be launched to ensure supply and parity sales

Ma Yisheng, chief engineer of the Department of Industry and Information Technology of Guangxi Zhuang Autonomous Region, introduced on the 30th that in order to alleviate the drug demand of people infected with the new crown virus in Guangxi and support the people to fight the epidemic, the "Guangxi Epidemic Prevention Drug Precision Delivery Platform" will be launched on December 31, providing targeted supply channels for Guangxi residents, and epidemic prevention materials are sold
at affordable prices.

 

The Information Office of the People's Government of Guangxi Zhuang Autonomous Region held a press conference on the prevention and control of the new coronavirus infection epidemic in Guangxi on the 30th to introduce relevant policies and measures
.

 

Ma Yisheng said at the meeting that promoting the stable production of Guangxi pharmaceutical enterprises, increasing the output of medical supplies for the new crown epidemic, and ensuring the adequate supply of pharmaceutical materials are the first priorities
of the current response to the epidemic.
The Department of Industry and Information Technology of Guangxi Zhuang Autonomous Region took the lead in setting up a special class for ensuring the supply of medical materials in the autonomous region, strengthening coordination, overcoming difficulties, and taking a multi-pronged approach to expand the production of
medical materials in every possible way.

 

According to the changes in the epidemic prevention and control situation in Guangxi, the Department of Industry and Information Technology of Guangxi Zhuang Autonomous Region has established a daily monitoring and scheduling system for key medical material production enterprises, comprehensively and accurately grasped the existing production capacity, current output and raw material inventory of enterprises, formulated implementation plans for increasing production in accordance with "one enterprise, one policy", accelerated the release of production capacity to ensure supply, carried out unified scheduling for key pharmaceutical manufacturers and key raw material enterprises, quickly activated idle production lines to run and put into operation quickly, and comprehensively improved equipment operating rate and capacity utilization rate.
Guide enterprises to quickly enter a full production state
.

 

At present, the production of pharmaceutical manufacturers covering colds, coughs, anti-inflammatory drugs and N95 masks in Guangxi is stable and orderly
.
Guilin Sanjin Pharmaceutical, Zhongheng Group, Guangxi Weiwei Pharmaceutical Co.
, Ltd.
and other local pharmaceutical companies in Guangxi are working overtime to produce drugs needed by the masses and actively launch them in the local market
.

 

Li Yongqiang, deputy director of the Health Commission of Guangxi Zhuang Autonomous Region, introduced at the meeting on the same day that at present, the demand for fever-reducing drugs and other categories in Guangxi tends to stabilize, and other anti-epidemic materials and drugs such as masks and alcohol are relatively sufficient to meet the needs of residents for drug purchase
.
At the same time, Guangxi requires all localities to reserve antiviral, fever-reducing and cough-suppressing drugs according to 20% of the population base of their jurisdiction, supervise and guide local medical and health institutions and drug retail institutions to reserve relevant therapeutic drugs and epidemic prevention materials, and regularly and dynamically report reserves and demand to ensure that people can purchase
them inside and outside hospitals, as well as online and offline.

 

It is reported that after the "Guangxi Epidemic Prevention Drug Precision Delivery Platform" is launched, people can enter the platform, complete the real-name authentication and pass the review, and then purchase anti-epidemic supplies
online.
The first batch of drugs released on the platform include ibuprofen, Lianhua Qingwen, Chinese medicine tablets, etc.
, all of which are sold
at affordable prices.
(End)